Clinical trial
Evaluation of the Efficacy of Immunotherapy in Uncommon Pathological Types of Lung Cancer
NCT05023837 is registered in ClinicalTrials.gov with Hunan Province Tumor Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy of Immunotherapy in Uncommon Pathological Types of Lung Cancer
- Lead sponsor
- Hunan Province Tumor Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 2, 2018
- Completion date
- August 3, 2021
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
uncommon pathological types of lung cancer